http://m.prnewswire.com/news-releases/esperance-pharmaceuticals-announces-completion-of-run-in-enrollment-of-phase-2-study-of-ep-100-plus-paclitaxel-in-advanced-ovarian-cancer-167661975.html
Sent from my iPhone
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.